Poland· PL-100158206
Duosol zawierający 2 mmol/l potasu
A hemofiltrates product containing preparat złożony, registered in Poland by B. Braun Avitum AG. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Preparat złożony is registered in 11 of 19 countries.
Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Preparat złożony · ATC B05ZB
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- B. Braun Avitum AG
- Country
- Poland (PL)
- ATC code
- B05ZB
- ATC class
- Hemofiltrates
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990430932
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05ZB
Hemofiltrates, as other registers publish it.
- BelgiumAccusol 35Nikkiso Belgium
- BelgiumAccusol 35 Kalium 2 mmol/lNikkiso Belgium
- BelgiumAccusol 35 Kalium 4 mmol/lNikkiso Belgium
- IrelandAccusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- FinlandBicaflac BufferB. Braun Avitum AG
- FinlandBicaflac Cum KaliumB. Braun Avitum AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f44454aa-ac20-4b93-9ea2-9561a798e7d8 GET /v1/drugs/f44454aa-ac20-4b93-9ea2-9561a798e7d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do hemofiltracji",
"source": "urpl",
"strength": "-",
"packaging": "05909990430932 ¦ Lz ¦ 25267\n2 worki 5000 ml",
"substance": "Sodu chlorek 4.21 g/1000 ml + Kalii chloridum 1.34 g/1000 ml + Calcii chloridum dihydricum 1.98 g/1000 ml + Magnesii chloridum hexahydricum 0.91 g/1000 ml + Glucosum monohydricum 9.9 g/1000 ml + Natrii hydrocarbonas 3.59 g/1000 ml",
"common_name": "Preparat złożony",
"pl_product_id": "100158206",
"pozwolenie_nr": "11997",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.